Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Samvardhana Motherson International posted a 46% YoY jump in Q4 FY26 profit to ₹1,561.56 crore, while FY26 revenue rose to ₹1,26,103.67 crore.
Aditya Birla Capital’s board approved a ₹4,000 crore preferential equity issuance led by promoter Grasim and IFC, priced at ₹356.02 per share, subject to approvals.
Social media chatter links the rupee’s record-low slide near 96 to the Hormuz energy shock, foreign outflows, a stronger dollar, and renewed balance-of-payments stress.
India’s IPO mood has softened amid West Asia-driven volatility, rising crude, FII outflows and weaker listings, even as a pipeline above ₹3 lakh crore stays intact.
Force Motors saw sharp share moves on monthly sales updates, mixed FY25-26 profit trends, and a SEBI information request tied to its Q2 FY25 results disclosure.
Jubilant FoodWorks reported a sharp rise in Q4 FY26 consolidated profit and higher revenue, while disclosures also highlighted a one-off gain linked to DP Eurasia.
KEC International’s Q4 FY26 profit and revenue miss pushed the stock near its 52-week low, prompting Axis Direct, PL Capital and HDFC Securities to cut targets while retaining ratings.
Whirlpool of India reported higher Q4 FY25 profit helped by improved margins and an insurance gain, and recommended a ₹5 final dividend for FY25 amid mixed share reaction.
UN and multiple agencies trimmed India’s FY27 growth projections as the West Asia conflict lifts crude prices, tightens financial conditions, and raises inflation and subsidy pressures.
JSW Dulux reported FY26 PAT of ₹1,973.8 crore driven by ₹1,845.9 crore exceptional gains from divestments, even as revenue from operations fell 12% and Q4 volumes rose 23%.
Motilal Oswal reiterated Buy on Varun Beverages, lifting its target to Rs 600 as earnings strengthened, margins improved and summer demand could rise amid heatwave forecasts.
The RBI will run a $5 billion USD/INR buy-sell swap auction for a three-year tenor, with $10 million minimum bids, to inject long-term rupee liquidity.
Dr Reddy’s secured CDSCO approval for generic oral semaglutide tablets and launched DCGI-approved Obeda injections at ₹4,200 per month, as patent and pricing battles intensify in India.
Sammaan Capital (formerly Indiabulls Housing Finance) reported a sharp Q4 FY26 loss after exceptional charges, impairment and higher Ind AS 109 provisions, alongside a year-on-year income decline.
Apollo Hospitals reported strong Q4 FY25 earnings, declared a Rs 10 final dividend with an August 19, 2025 record date, and later announced an interim dividend for FY26.
Apollo Hospitals’ Q4 FY25 profit rose 53.5% year-on-year to ₹390 crore on 13% revenue growth, while the board recommended a final dividend of ₹10 per share.